Mycobacterium abscessus treatment outcomes in cystic fibrosis: A single centre experience.

J Cyst Fibros

Molecular Immunity Unit, Department of Medicine, University of Cambridge, Cambridge, UK; Cambridge Centre for Lung Infection (CCLI), Royal Papworth Hospital, Cambridge, UK; Heart Lung Research Institute, University of Cambridge, Cambridge, UK.

Published: July 2024

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcf.2024.07.016DOI Listing

Publication Analysis

Top Keywords

mycobacterium abscessus
4
abscessus treatment
4
treatment outcomes
4
outcomes cystic
4
cystic fibrosis
4
fibrosis single
4
single centre
4
centre experience
4
mycobacterium
1
treatment
1

Similar Publications

Mycobacterium abscessus is a rapidly growing nontuberculous mycobacterium that causes severe pulmonary infections. Recent studies indicate that ferroptosis may play a critical role in the pathogenesis of M. abscessus pulmonary disease.

View Article and Find Full Text PDF

Interferon-gamma (IFN-γ) autoantibody syndrome is an emerging clinical entity that has been associated with disseminated non-tuberculous mycobacterial infection (dNTM) particularly in healthy young people, a population not previously thought to be at particular risk. A 29-year-old South-East Asian man presented with several weeks of fever, cough, lymphadenopathy, and constitutional symptoms while working on an international cargo ship, deteriorating rapidly with a sepsis-like syndrome. Eventually lymph node and sputum cultures revealed a diagnosis of dNTM infection with growth of both Mycobacterium persicum and Mycobacterium abscessus.

View Article and Find Full Text PDF

Infections Management in the Lung Transplant Setting in Italy: A Web-Survey.

Transpl Infect Dis

January 2025

Unit of Infectious Diseases and Infection Control, ISMETT-IRCCS Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione, Palermo, Italy.

Introduction: Infections significantly impact morbidity and mortality in lung transplant (LuTx) recipients. This survey focused on documenting current practices regarding the prevention and management of infections in LuTx in Italy.

Methods: A 52-question survey was administered online in the period from December 1, 2023, to January 31, 2024, assessing center characteristics, Tx team organization, microbiological investigations, infection prevention, and management.

View Article and Find Full Text PDF

Mycobacterium tuberculosis (M. tuberculosis) and Mycobacterium abscessus (M. abscessus) are important pathogens that can cause lung diseases.

View Article and Find Full Text PDF

Drugs must accumulate at their target site to be effective, and inadequate uptake of drugs is a substantial barrier to the design of potent therapies. This is particularly true in the development of antibiotics, as bacteria possess numerous barriers to prevent chemical uptake. Designing compounds that circumvent bacterial barriers and accumulate to high levels in cells could dramatically improve the success rate of antibiotic candidates.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!